International Clinical Trial: Treatment response assessment for breast cancer after neoadjuvant therapy with post-treatment MRI using annotation-free foundation model

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132742) titled 'Treatment response assessment for breast cancer after neoadjuvant therapy with post-treatment MRI using annotation-free foundation model' on Sept. 17.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Yunnan Cancer Hospital

Condition: Breast cancer

Intervention: Gold Standard:Postoperative pathology as gold standard after breast surgery following neoadjuvant therapy. pCR defined as ypT0/is and ypN0 (no residual invasive breast cancer or axillary nodal metastasis).

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-20

Target Sample S...